Stocks and Investing Stocks and Investing
Wed, March 29, 2023
Tue, March 28, 2023
Mon, March 27, 2023
Fri, March 24, 2023

Leland Gershell Maintained (XFOR) at Buy with Decreased Target to $4 on, Mar 24th, 2023


Published on 2024-10-28 02:24:14 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Buy with Decreased Target from $5 to $4 on, Mar 24th, 2023.

Leland has made no other calls on XFOR in the last 4 months.



There are 3 other peers that have a rating on XFOR. Out of the 3 peers that are also analyzing XFOR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy and Held Target at $3 on, Wednesday, March 22nd, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $3 on, Wednesday, March 22nd, 2023
  • Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022